You are here

Article info

Article menu
Download PDFPDF
Editorial commentaries
Biomarkers for dementia diagnosis: differentiating DLB and FTD may be difficult

Authors

  • Dag Aarsland Department of Neurobiology, Ward and Society, Alzheimer's Disease Research Centre, Karolinska Institutet, Stockholm, Sweden Centre for Age-Related Diseases, Stavanger University Hospital, Stavanger, Norway PubMed articlesGoogle scholar articles
  • Clive G Ballard Wolfson Centre for Age-Related Diseases, King's College London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Dag Aarsland, Department of Neurobiology, Ward and Society, Alzheimer's Disease Research Centre, Karolinska Institutet, Novum, Huddinge, 171 77 Stockholm, Sweden; daarsland{at}gmail.com
View Full Text

Citation

Aarsland D, Ballard CG
Biomarkers for dementia diagnosis: differentiating DLB and FTD may be difficult
Journal of Neurology, Neurosurgery & Psychiatry 2012;83:1037.

Publication history

  • Received May 25, 2012
  • Accepted June 6, 2012
  • First published August 6, 2012.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions